Funded Projects › H2020
STARS · Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)
Lack of specific relevant know-how in regulatory science delays the development of new treatment strategies or limits the chances that promising innovations will reach patients. STARS aims to improve the direct regulatory impact of results obtained in medical research. Seventeen European countries are represented in the consortium through their national competent authorities, alongside academic and industry representatives, and associations with relevant experience.The work plan includes the development of a Comprehensive Inventory of existing support activities based on a detailed analysis of the currently established programmes. This analysis is also the basis for development of a Common Strategy to strengthen regulatory sciences and two curricula, the Core Curriculum specifying essential knowledge for the professional training of clinical scientists and the Comprehensive Curriculum defining relevant knowledge for specific post-graduate programmes. Three pilot projects aim (i) to transfer an identified best practice example for training programmes to other EEA countries, (ii) to implement a new support activity addressing a gap in regulatory knowledge of significant relevance and (iii) to implement the Comprehensive Curriculum. STARS will deliver consensual recommendations ensuring sustainable support of academic research and will propose additional support mechanisms based on a comprehensive analysis of needs. STARS has the objective and the potential to complement, coordinate and harmonise regulatory efforts among Member States and at European level to support academic health research for the benefit of patients. The aim is to reach academic researchers very early in the planning of relevant grant applications. A further aim is to strengthen regulatory knowledge in general by reaching clinical scientists during professional training and qualification.
Consortium · 21 organisations
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE
DE · €190,000
STATNI USTAV PRO KONTROLU LECIV
CZ · €22,125
ZALU VALSTS AGENTURA
LV · €14,625
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY
UK · €40,875
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS
ES · €75,000
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL
DE · €190,000
NEMZETI NEPEGESZSEGUGYI ES GYOGYSZERESZETI KOZPONT
HU · €52,500
AGES - OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT GMBH
AT · €33,750
LAAKEALAN TURVALLISUUS-JA KEHITTAMISKESKUS
FI · €112,500
DEUTSCHES ZENTRUM FUR LUFT - UND RAUMFAHRT EV
DE · €680,000
HEALTH PRODUCTS REGULATORY AUTHORITY
IE · €37,500
URZAD REJESTRACJI PRODUKTOW LECZNICZYCH, WYROBOW MEDYCZNYCH I PRODUKTOW BIOBOJCZYCH
PL · €53,250
AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE
FR · €30,000
LAKEMEDELSVERKET
SE · €86,250
AGENZIA ITALIANA DEL FARMACO
IT · €57,000
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN
NL · €120,000
VALSTYBINE VAISTU KONTROLES TARNYBAPRIE LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJOS
LT · €42,500
INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP
PT · €22,500
FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS
BE · €35,625
THE MEDICINES AUTHORITY
MT · €82,500
THE EUROPEAN MEDICINES AGENCY
NL · €7,500
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.